Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Delta Hepatitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05827146
What this trial is testing

Study of Hepalatide in Chronic Hepatitis D(CHD) Patients

Who this might be right for
Chronic Hepatitis D Infection
Shanghai HEP Pharmaceutical Co., Ltd. 23
Not applicableEnded earlyNCT01861444
What this trial is testing

An Observational Study on the Prevalence of Chronic Hepatitis D in Romania and the Efficacy of Treatment With Pegasys (Peginterferon Alfa-2a)

Who this might be right for
Hepatitis D, Chronic
Hoffmann-La Roche 45
Testing effectiveness (Phase 2)Study completedNCT02430181
What this trial is testing

Lonafarnib With and Without Ritonavir in HDV (LOWR-1)

Who this might be right for
Chronic Hepatitis D Infection
Eiger BioPharmaceuticals 21
Not applicableLooking for participantsNCT04690972
What this trial is testing

"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".

Who this might be right for
Chronic Liver Disease and CirrhosisLiver CancerNon-Alcoholic Fatty Liver Disease+4 more
Institut National de la Santé Et de la Recherche Médicale, France 800
Large-scale testing (Phase 3)Study completedNCT00686790
What this trial is testing

Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603)

Who this might be right for
Hepatitis D, ChronicHepatitis B, Chronic
Merck Sharp & Dohme LLC 68
Not applicableNo Longer AvailableNCT05683548
What this trial is testing

Replicor Compassionate Access Program

Who this might be right for
Viral Hepatitis BViral Hepatitis DCirrhosis, Liver+4 more
Replicor Inc.
Testing effectiveness (Phase 2)UnknownNCT03099278
What this trial is testing

Ezetimibe for Patients With Chronic Hepatitis D

Who this might be right for
Chronic Hepatitis D
Ziauddin Hospital 20
Post-approval studies (Phase 4)UnknownNCT00117533
What this trial is testing

Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta

Who this might be right for
Chronic Hepatitis BChronic Hepatitis D
National Taiwan University Hospital 20
Large-scale testing (Phase 3)Active Not RecruitingNCT06907290
What this trial is testing

A Trial Evaluating BJT-778 vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection

Who this might be right for
Chronic Hepatitis D Infection
Mirum Pharmaceuticals, Inc. 150
Testing effectiveness (Phase 2)UnknownNCT03105310
What this trial is testing

Pegylated Interferon Alone or in Combination With Ezetimibe for Patients With Chronic Hepatitis D

Who this might be right for
Hepatitis D, Chronic
Aga Khan University 20
Post-approval studies (Phase 4)Ended earlyNCT01264094
What this trial is testing

Evaluate the Efficacy and the Change of sAg Levels in Chronic Hepatitis B Patients Receiving Clevudine Treatment Over the Long Period

Who this might be right for
Chronic Hepatitis B
Bukwang Pharmaceutical 200
Post-approval studies (Phase 4)Study completedNCT01639092
What this trial is testing

Tenofovir vs. Tenofovir Plus Entecavir in Entecavir-Resistant Chronic Hepatitis B

Who this might be right for
Chronic Viral Hepatitis B Without Delta-agent
Asan Medical Center 88
Large-scale testing (Phase 3)Looking for participantsNCT07454837
What this trial is testing

Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide

Who this might be right for
Chronic Hepatitis D
Mirum Pharmaceuticals, Inc. 120
Not applicableStudy completedNCT02876419
What this trial is testing

A Long Term Follow-up Study of Patients From the REP 301 Protocol

Who this might be right for
Hepatitis B, ChronicHepatitis D, Chronic
Replicor Inc. 11
Large-scale testing (Phase 3)Active Not RecruitingNCT06903338
What this trial is testing

Evaluate Tobevibart + Elebsiran in Chronic HDV Infection

Who this might be right for
Viral Hepatitis
Vir Biotechnology, Inc. 124
Large-scale testing (Phase 3)Looking for participantsNCT07200908
What this trial is testing

A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)

Who this might be right for
Chronic Hepatitis D Infection
Mirum Pharmaceuticals, Inc. 172
Large-scale testing (Phase 3)Active Not RecruitingNCT07128550
What this trial is testing

Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not Virologically Suppressed With Bulevirtide

Who this might be right for
Viral Hepatitis
Vir Biotechnology, Inc. 150
Post-approval studies (Phase 4)Study completedNCT01639066
What this trial is testing

Tenofovir Plus Entecavir vs. Tenofovir in Adefovir-Resistant Chronic Hepatitis B

Who this might be right for
Chronic Viral Hepatitis B Without Delta-agent
Asan Medical Center 102
Testing effectiveness (Phase 2)Ended earlyNCT02577029
What this trial is testing

Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV)

Who this might be right for
Hepatitis BHepatitis D
Arrowhead Pharmaceuticals 79
Not applicableLooking for participantsNCT04166266
What this trial is testing

National Cohort of Patients Co-infected With Hepatitis B and Delta Viruses

Who this might be right for
Hepatitis D, ChronicHepatitis B, Chronic
ANRS, Emerging Infectious Diseases 800
Next Page